i am working on article. it will be out soon. i love the ibio story, and i love the highly speculative near term catalyst on the calender. i love the long term value the platform offers as an investment.
no questions please, everyone here already knows what i might be discussing.
i hope its ok.
good luck everyone
The Wall Streert Journal will be seen by far more "investors" than Seeking Alpha which is notorius for creating a 1 to 2 day momentum move. When more people see the potential and understand the signifigance of the lock up with the new patents here at IBIO it should see new highs in the price per share.
The biggest catalyst in the near term will be an announcement of a contract with a big pharma Co. to prove to everyone that IBIO technique to produce vaccines is far safer, faster, and profitable as we all know it to be.
The IBIO Launch does not only produce vaccines faster, it produces ALL BIOLOGICS in this fashion. The newer investors have not fully grasped this concept yet.
Julian, I am excited to read your article. Will we have access to read this tomorrow as well?
Thanks JC, if I can help in anyway please let me know. I appreciate everything you have posted here. It allowed me to get up to speed very quickly. I think this company has the potential to fundamentally change things the way Microsoft with DOS, and programs such as VisiCalc initiated the age of the PC.
what is the % of pt population allergic to mammalian cell based drugs?
i realize there are several ways to answer this question and that in some ways, allergy can inhibit the functionality of antigen, but thats not what im looking for.
this figure is the potentially expanded pt pop. using ibiolaunch platform for production compared to traditional incumbent methods where patients can receive best in class treatment option.